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KEY POINTS  30	
Accidental hypothermia was the primary or secondary diagnosis in over 100,000 hospital 31	
admissions from 2005 to 2015 in the United Kingdom. In this study we sought to determine 32	
whether acetaminophen, a non-prescription drug used to manage mild pain and fever, reduced 33	
core temperature stability during a 2-hour passive cold or thermoneutral exposure.  34	
Acetaminophen had no effect on core temperature in thermoneutral conditions compared with a 35	
placebo, but reduced core temperature by up to 0.57°C after 2-hours cold exposure. The present 36	
results improve our knowledge about the side-effects of acetaminophen and provides important 37	
information of relevance for hypothermia pathology. 38	
  39	
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ABSTRACT  40	
Background: Acetaminophen is an over-the-counter drug used to treat pain and fever, but it has 41	
also been shown to reduce core temperature (Tc) in the absence of fever. However, this side-42	
effect is not well examined in humans, and it is unknown if the hypothermic response to 43	
acetaminophen is exacerbated with cold exposure. 44	
Objective: To address this question, we mapped the thermoregulatory responses to 45	
acetaminophen and placebo administration during exposure to acute cold (10°C) and thermal 46	
neutrality (25°C).  47	
Methods: Nine healthy Caucasian males (age: 20 to 24 years) participated in the experiment. In a 48	
double-blind, randomised, repeated measures design, participants were passively exposed to a 49	
thermo-neutral or cold environment for 120-minutes, with administration of 20 mg/kg lean body 50	
mass acetaminophen or a placebo 5-minutes prior to exposure. Tc, skin temperature (Tsk), heart 51	
rate, and thermal sensation were measured every 10-minutes, and mean arterial pressure was 52	
recorded every 30-minutes. Data were analysed using linear mixed effects models. Differences in 53	
thermal sensation were analysed using a cumulative link mixed model.  54	
Results: Acetaminophen had no effect on Tc in a thermo-neutral environment, but significantly 55	
reduced Tc during cold exposure, compared with a placebo. Tc was lower in the acetaminophen 56	
compared with the placebo condition at each 10-minute interval from 80 to 120-minutes into the 57	
trial (all p < 0.05). On average, Tc decreased by 0.42 ± 0.13°C from baseline after 120 minutes of 58	
cold exposure (range 0.16 to 0.57°C), whereas there was no change in the placebo group (0.01 ± 59	
0.1°C). Tsk, heart rate, thermal sensation, and mean arterial pressure were not different between 60	
conditions (p > 0.05).  61	
Conclusion: This preliminary trial suggests that acetaminophen-induced hypothermia is 62	
exacerbated during cold stress. Larger scale trials seem warranted to determine if acetaminophen 63	
administration is associated with an increased risk of accidental hypothermia, particularly in 64	
vulnerable populations such as frail elderly individuals.  65	
 66	
Key Words: acetaminophen, paracetamol, thermoregulation, cold exposure, thermogenesis, 67	
hypothermia 68	
69	
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1.1 INTRODUCTION 70	
Accidental hypothermia is characterised by an unintended core temperature (Tc) reduction to 71	
35°C or lower. Such a fall in Tc can induce ventricular fibrillation and ultimately cardiac arrest if 72	
Tc declines to < 28ºC [1, 2]. In the United States, hypothermia was the cause or contributing 73	
cause of death in over 5500 cases between 2006 and 2010 [3], but this is likely underestimated 74	
since Tc needs to be measured at or near the time of death. Nonetheless, data from United 75	
Kingdom hospital episode statistics indicate that hypothermia was the primary or secondary 76	
diagnosis in over 100,000 hospital admissions from 2005 to 2015 [4]. Although death from 77	
hypothermia is rare, it remains a significant health risk in elderly and very young individuals, 78	
particularly during winter months and unaccustomed cold spells [1]. Interestingly, there is a 79	
growing body of evidence demonstrating that acetaminophen could reduce Tc stability during 80	
cold exposure (discussed below), placing users at an increased risk of accidental hypothermia.  81	
Acetaminophen is an over-the-counter drug marketed as paracetamol in Europe and Tylenol in 82	
the United States. It is best known for its ability to decrease pain perception and reduce Tc during 83	
a fever; each of these actions are in part mediated through an inhibition of cyclooxygenase 84	
(COX) enzyme activity [5]. However, there is evidence of a ‘hypothermic’ action of 85	
acetaminophen, which refers specifically to an acetaminophen-induced reduction in Tc 86	
independent of febrile status. In mice, high doses (150 to 300 mg/kg body mass) administered 87	
intravenously reduced Tc by 2 to 4°C [6–8]. In humans, there have been 246 reports in Vigibase© 88	
(the World Health Organisation international database of adverse drug reactions) specific to 89	
acetaminophen-induced  accidental hypothermia [9]. In addition, several case studies report 90	
profound hypothermia following therapeutic doses [10] and high doses of acetaminophen when 91	
ingested orally [11, 12]. Finally, oral acetaminophen administration (20 mg/kg lean body mass) 92	
reduced Tc in young adults by ~0.2°C (range, 0.10 to 0.39°C) during exposure to mild cold [13]. 93	
Although the Tc reductions were small, this hypothermic side-effect of acetaminophen occurred 94	
in all thirteen participants. Despite this data, additional criteria, such as the environmental 95	
temperature, are needed to accurately predict when acetaminophen poses the greatest risk for 96	
hypothermia development. Since the COX pathway could be involved in non-febrile 97	
thermogenesis [14, 15], inhibition of this enzyme by acetaminophen might cause Tc to fall during 98	
cold exposure, while exerting negligible effects on Tc while exposed to a warm environment.   99	
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If acetaminophen-induced hypothermia is a risk during cold exposure, this can have major 100	
implications for public health recommendations. Each year in the United States, ~6% of adults 101	
are prescribed acetaminophen at doses of more than 4 g/day [16], while it is also available over-102	
the-counter without prescription. Acetaminophen is recommended as the first line analgesic for 103	
the elderly because it has minimal drug interactions and is well tolerated when taken at 104	
recommended doses [17]. It is also recommended for use in neonatal intensive care units 105	
following minor procedures and circumcision [18, 19]. Each of these age groups have a high 106	
incidence of accidental hypothermia due to a decreased ability to produce heat and make 107	
perceptually driven behavioural changes [20, 21]. Due to its hypothermic effects, use of 108	
acetaminophen in these populations could decrease their Tc to the point in which they are 109	
clinically hypothermic. However, the question remains as to whether acetaminophen exerts its 110	
hypothermic effect by increasing heat loss, or decreasing heat production. If the COX pathway is 111	
required for full heat production, inhibition of its activity by acetaminophen would cause Tc to 112	
fall during cold exposure while exerting no hypothermic action during a thermo-neutral exposure 113	
(in which no heat production is required).     114	
The aim of this trial was to examine the thermoregulatory response to acetaminophen 115	
administration (20 mg/kg of lean body mass) during a 120-minute exposure to a thermo-neutral 116	
and cold environment in healthy adult humans. Due to a potential role of COX in non-febrile 117	
thermogenesis [14, 15], it was hypothesised that acetaminophen would reduce Tc in cold 118	
conditions, but have no effect on Tc in thermo-neutral conditions relative to a placebo. 	119	
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1.2 METHODS 120	
1.2.1 Ethical Approval 121	
Experimental procedures were approved by the University Research Ethics committee (approval 122	
code 2014ISPAR011). All experimental procedures conformed to the standards set by the World 123	
Association Declaration of Helsinki ‘Ethical Principles for Research Involving Human Subjects’. 124	
1.2.2 Sample Size Calculation  125	
Power analyses were conducted with GPower software version 3.1 (Heinrich University, 126	
Düsseldorf, Germany) to determine the sample necessary to achieve two-tailed statistical 127	
significance (α = 0.05), with a power of 0.90 and a partial eta-squared (η2) of 0.42. Using Tc data 128	
from a previous experiment where acetaminophen was tested as a hypothermic agent [22], it was 129	
determined that nine participants were required to reach the statistical power. If acetaminophen 130	
exerts the hypothesised hypothermic response, a larger project within vulnerable populations 131	
may be warranted to determine if acetaminophen contributes to accidental hypothermia 132	
admissions.  133	
1.2.3 Participants  134	
Nine Caucasian males [age: 22 ± 1 years, height: 179 ± 5 cm, body mass: 80.7 ± 11.9 kg, body 135	
fat (20 ± 5%)] volunteered to take part in this study. Participants were provided with written 136	
information regarding the experimental procedures, with supporting oral explanations from the 137	
principal investigator. All participants subsequently provided written informed consent. The 138	
participants were non-smokers, non-febrile (resting Tc < 38°C), and free from musculoskeletal 139	
injury. 140	
1.2.4 Inclusion & Exclusion Criteria 141	
Prior to each laboratory visit, participants completed an alcohol use disorder identification test 142	
[AUDIT; [23]], a breathalyser test (AlcoSense, One, Berkshire, UK), and an acetaminophen risk 143	
assessment questionnaire. To avoid any risk of liver damage inflicted by acetaminophen, 144	
participants were not able to participate in the research if they scored above ten on the AUDIT 145	
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questionnaire or alcohol was present in their bloodstream (i.e. > 0% blood alcohol content). In 146	
addition, the acetaminophen dose was relative to lean body mass, as it is a closer indicator of 147	
liver volume than total body mass [24]. No participants presented with any pre-existing medical 148	
conditions that may have put them at an increased risk of acetaminophen toxicity. Due to 149	
potential thermoregulatory adaptations [25, 26], individuals were not permitted to take part in 150	
any experimental procedures if they were heat/cold acclimated or acclimatised. Thus, those who 151	
had travelled to a hot/cold climate or participated in a laboratory based heat/cold acclimation 152	
protocol less than three weeks before the experiment were not permitted to take part. All 153	
participants presented to the laboratory with a stable resting Tc of 36.5-37.5°C. 154	
1.2.5 Experimental Design  155	
A schematic of the experimental design is displayed in Figure 1. To determine if acetaminophen 156	
reduces Tc stability during cold stress compared to a placebo, the participants visited the 157	
laboratory on five occasions, each separated by at least seven days. On visit 1, participants 158	
arrived fasted (overnight) and their body fat was assessed via air displacement plethysmography 159	
(Bod Pod, 2000A, Birmingham, UK). The body fat reading from this test was used to determine 160	
the participant’s dose of acetaminophen received in the experimental trials. Visits 2-5 161	
(experimental trials) were randomised (SPSS Inc., Chicago, USA), double blinded (drug only), 162	
and followed a repeated measures design. On these visits, participants were exposed to either 163	
cold [10°C, 40% relative humidity (r.h)] or thermo-neutral (25°C, 40% r.h.) environmental 164	
temperatures for 120 minutes, having been administered acetaminophen (20 mg/kg of lean body 165	
mass) or a placebo (dextrose). Acetaminophen (Paracetamol, Aspar Pharmaceuticals, London, 166	
UK) was administered via the oral route. The placebo was matched in terms of appearance i.e. 167	
the same number of capsules were provided to the participants. The average dose of 168	
acetaminophen administered in the present work was 1,287 ± 173 mg (range, 1,082 to 1,486 mg). 169	
 170	
***please insert Figure 1 near here*** 171	
 172	
1.2.6 Experimental Protocol 173	
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All participants arrived at the laboratory at 10:00. Upon arrival, participants were instrumented 174	
for the measurement of Tc, skin temperature (Tsk), and heart rate (see “Instrumentation and 175	
Equations” for details). Thirty minutes after arrival participants consumed a standardised 176	
breakfast [cornflakes (50 g), milk (250 ml) and 1 litre of tap water] and ingested acetaminophen 177	
or a placebo one hour after the meal was consumed. Participants remained rested in an upright, 178	
seated position between meal consumption and acetaminophen or placebo ingestion to ensure 179	
resting physiological status was attained. Participants were wheeled into the environmental 180	
chamber immediately following drug administration, and remained in the seated position for the 181	
duration of the protocol. Clothing was shorts and calf length socks, representing a Clo value of 182	
~0.1. Resting measurements of Tc, Tsk, heart rate and thermal sensation were collected five 183	
minutes prior to acetaminophen and placebo ingestion, and subsequently every 10 minutes for 184	
120 minutes’ post-ingestion. Blood pressure was measured prior to chamber entry and every 30 185	
minutes (pre-ingestion, 30, 60, 90, 120 minutes post-ingestion) until the end of the trial. Data in 186	
Tables 1 and 2 provide the mean and range for each variable (Tc, Tsk, heart rate, and MAP) at 30-187	
minute intervals.  188	
1.2.7 Instrumentation and Equations 189	
Tc was measured via insertion of a rectal thermistor (Henleys Medical Supplies, 400H/4491H, 190	
Hertfordshire, UK) 10 cm beyond the anal sphincter. The thermistor was connected via cable to a 191	
portable data logger (Libra Medical, ET402, Birmingham, UK), in which Tc was continuously 192	
displayed throughout each experimental protocol. This was only visible to the researchers, not 193	
the participants. 194	
Copper based thermocouples (Grant, EUS-U-VS5-0, Dorset, UK) connected to a wireless data 195	
logger (Grant, Squirrel Series, Dorset, UK) recorded Tsk at four sites: calf, thigh, chest, and 196	
triceps [27]. Thermocouples were securely attached to the belly of each muscle by hypafix 197	
surgical adhesive tape (BSN medical, D-22771, Hamburg, Germany). The weighted Tsk of four 198	
sites was subsequently calculated using the equation below [27]: 199	
 200	
Mean Tsk = 0.3×(Tarm + Tchest) + 0.2×(Tcalf + Tthigh) 201	
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Thermal sensation was obtained using a 0 to 8 scale ranging from unbearably cold (0) to 203	
unbearably hot (8). Heart rate was measured during all tests using short-range telemetry (Polar, 204	
FS1, Warwick, UK), and was expressed as beats per minute (b/min). 205	
Blood pressure was measured using a portable blood pressure monitor (Omron M5-1, Omron, 206	
Milton Keynes, UK). Measurements were taken at baseline (pre), and every 30 minutes of the 207	
120-minute exposure period. Mean arterial pressure (MAP) was later calculated as [(2 × DBP) + 208	
SBP]/3 mmHg. 209	
1.2.8 Statistical Analysis  210	
All statistical analyses were performed using the ‘nlme’, ‘ordinal’, ‘ez’, ‘sjPlot’ and ‘stats’ 211	
packages in R version 3.3.2 (R Core Development Team 2014). Normality assumptions were 212	
checked using quantile-quantile plots [28] and were plausible in all instances. Central tendency 213	
and dispersion are reported as means ± standard deviation (SD). The Akaike information criteria 214	
(AIC) was used to determine model fit [29]. The correlation structure with the lowest AIC was 215	
chosen based on this procedure. A linear mixed model with fixed (‘drug’, ‘time’) and random 216	
(‘subject i.d’) effects was fitted with an autoregressive correlation structure (to account for 217	
autocorrelation) to examine the effect of acetaminophen on Tc, Tsk, and heart rate in thermo-218	
neutral and cold conditions [Time (13 levels): pre, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 219	
120 minutes × Drug (2 levels): placebo, acetaminophen]. The same model with different levels 220	
of time [Time (5 levels): pre, 30, 60, 90, 120 minutes) × Drug (2 levels): placebo, 221	
acetaminophen] was fitted to determine the effect of acetaminophen on MAP in thermo-neutral 222	
and cold conditions. A cumulative link model was used to compare thermal sensation scores 223	
between placebo and acetaminophen in the thermo-neutral and cold conditions. The two-tailed 224	
alpha level of significance testing was set as p ≤ 0.05. 95% confidence intervals (CI) are 225	
presented to denote the imprecision of the point estimate.  226	
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1.3 RESULTS 227	
1.3.1 Thermo-neutral 228	
There was no main effect for drug or interaction effect (drug × time) for Tc, Tsk, heart rate, TSS, 229	
or MAP. A main effect for time was present in each of these variables apart from MAP, showing 230	
that Tc, Tsk, heart rate and TSS changed (p < 0.05) over time with no differences observed 231	
between acetaminophen and placebo. Descriptive (mean ± SD) data for each 30-minute interval 232	
is shown in Table 1.  233	
1.3.2 Cold 234	
The Tc response during cold exposure differed between the acetaminophen and placebo 235	
conditions. An interaction effect (F1,12 = 2.25, p = 0.01), main effect for drug (F1,2 = 2.25, p < 236	
0.01), and main effect for time (F1,12 = 8.33, p < 0.01) was found between placebo (37.06 ± 237	
0.20°C; 95% CI = 36.99 to 37.12°C) and acetaminophen (36.90 ± 0.32°C; 95% CI = 36.79 to 238	
37.01°C). Specifically, Tc was 0.18, 0.19, 0.22, 0.27, 0.29 and 0.35°C lower in the 239	
acetaminophen trial at time points 70 to 120 minutes compared with the placebo. The peak Tc 240	
reduction in the nine participants (120 minute compared with baseline) was 0.16 to 0.57°C 241	
(mean = 0.40 ± 0.15°C). Mean and individual Tc responses over the 120-minute exposure period 242	
are displayed in Figures 2 and 3 respectively.  243	
There were no main effects for drug or interaction effect between drug and time for Tsk, heart 244	
rate, TSS, or MAP. A main effect for time was present in each of these variables excluding 245	
MAP. All descriptive data for each30 minute interval is shown in Table 2. For Tc, Table 3 246	
displays the model’s fixed effects coefficients and random effect variances.    247	
***please insert Table 1 & 2 near here*** 248	
***please insert Figure 2 near here*** 249	
***please insert Figure 3 near here*** 250	
***please insert Table 3 near here*** 251	
  252	
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1.4 DISCUSSION  253	
It was hypothesised that acetaminophen would reduce Tc in cold conditions, but have no effect 254	
on Tc in thermo-neutral conditions relative to a placebo. The experimental hypothesis was 255	
accepted. The major finding of the present study was that, compared with a placebo, 256	
acetaminophen administration reduced Tc (0.16 to 0.57°C decrease after 120 minutes exposure) 257	
during an acute cold stress (10°C), while it appeared to have no effect on thermoregulation at a 258	
thermo-neutral ambient temperature (25°C). During cold exposure, acetaminophen caused Tc to 259	
fall by ~0.40°C compared with the baseline value at 120 minutes, while it did not decline in the 260	
placebo trial. The variability in the response may be due to between subject differences in the 261	
rate of acetaminophen absorption, but unfortunately this was not analysed in this trial. The 262	
hypothermic response to acetaminophen ingestion observed in the current study corroborates our 263	
prior work in humans, in which acetaminophen reduced Tc by ~0.19°C in humans exposed to 264	
mild cooling [13]. Furthermore, this is the first study to demonstrate that the ambient temperature 265	
can dictate the degree of hypothermia induced by acetaminophen. During cold exposure, this 266	
trial shows that healthy young adults could not defend their Tc following acetaminophen 267	
administration (Figure 2). Given that elderly individuals already struggle to defend their Tc 268	
without prior drug ingestion [20], it is reasonable to suspect that acetaminophen would cause Tc 269	
to decline at a faster rate, increasing the risk of accidental hypothermia.    270	
The notion that ambient and skin temperature dictates the magnitude of acetaminophen’s 271	
hypothermic action is in line with previous research. In a recent experiment, acetaminophen (20 272	
mg/kg) had no effect on sweat output and Tc during 1-hour exercise in hot conditions (34°C, 52% 273	
r.h.) at a fixed rate of heat production (8 W/kg) [30]. In that study, the mean skin temperature 274	
increased by 1°C during the trial (up to ~35°C), a condition in which no heat producing 275	
mechanisms will be active [31, 32]. Because the mean skin temperature during cold stress was 276	
~24°C at the end of the trial (Figure 2), cutaneous vasoconstriction and active thermogenesis 277	
were required for Tc to remain stable [33, 34]. The presence of thermogenesis and 278	
vasoconstriction indicates that acetaminophen may reduce Tc through inhibition of at least one of 279	
these mechanisms, but the precise mechanism needs to be confirmed in future work. Previous 280	
data demonstrated that acetaminophen reduced Tc by 0.10 to 0.39°C (mean ± SD, 0.19 ± 0.09°C) 281	
at rest when the mean skin temperature was ~27°C [13]. Similar reductions in skin temperature 282	
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induce shivering thermogenesis [33], which, if inhibited by acetaminophen, may explain the 283	
small reduction in Tc seen previously [13].  284	
Studies in mice have shown Tc fell by 0.40, 0.80, and 2°C following 1-hour acetaminophen 285	
infusion of 100, 200, and 300 mg/kg body mass respectively [14]. Thus, acetaminophen-induced 286	
hypothermia is not only dependent on ambient temperature, but also on the dose administered. It 287	
is important to note here that mice are often housed in environments of 18 to 20°C, which is 8 to 288	
10°C beneath their normal thermo-neutral zone [35]. These housing conditions are consistent in 289	
experiments concerning acetaminophen-induced hypothermia in rodents [6, 8, 14], such that 290	
these animals constantly produce heat to maintain their Tc. Inhibition of this heat production 291	
through acetaminophen may explain its hypothermic action, a notion that should be confirmed 292	
through the administration of high dose acetaminophen in mice housed within and below their 293	
thermo-neutral zone (i.e. 30°C and 20°C, respectively).  294	
It is possible that the acetaminophen-induced reduction in Tc observed in the present study was 295	
due to inhibition of cyclooxygenase (COX). There are two COX isoforms (COX-1 and -2), and 296	
their function is to convert arachidonic acid to prostaglandin (PG) H2 [36], which cell-specific 297	
isomerases and synthases then convert to prostanoids [(PGE2, PGF2, PGD2, PGI2, and 298	
thromboxane A2 (TXA2)]. The  strongest evidence that acetaminophen-induced hypothermia is 299	
mediated through COX inhibition was provided by Ayoub and colleagues [14], who 300	
demonstrated that acetaminophen reduced Tc by 4°C in wild-type mice, but by only 1.5°C in a 301	
COX-1-/- strain. In addition, they showed a strong relationship between brain PGE2 302	
concentrations and Tc, where the maximum reduction in Tc was met with a 96% reduction in 303	
brain PGE2. Data supporting a role for a COX-1 splice variant (COX-1b) in the hypothermic 304	
effect of acetaminophen is equivocal. While infusion of putative COX-1b inhibitors aminopyrene 305	
and antipyrene exert a similar hypothermic effect to acetaminophen [14, 37], genetic studies 306	
suggest that the human COX-1b gene produces a non-functional protein because it retains intron-307	
1 [38]. Even when this was corrected via site-directed mutagenesis, acetaminophen did not 308	
inhibit COX-1b activity [39]. Taken together, these studies suggest that COX-1 mediated PGE2 309	
production may be required for normal Tc maintenance in mammals housed in sub-neutral 310	
ambient temperatures, while COX-1b is unlikely to be involved. If this were true, similar 311	
hypothermic responses would be expected with non-selective COX inhibitors Ibuprofen and 312	
13	
	
Aspirin, or SC-560, a COX-1 specific inhibitor. Whether these drugs initiate a loss of Tc control 313	
during cold exposure has not yet been determined.  314	
Given acetaminophen reduced Tc stability in healthy adult males (Figure 2), its hypothermic 315	
effect is likely to be larger in populations already considered vulnerable in sub-neutral ambient 316	
temperatures (i.e. the very young and the elderly). Accidental hypothermia is a rising global 317	
health concern. In the USA, the Centre for Disease Control and Prevention report that 318	
hypothermia was the cause of nearly 17,000 deaths from 1999 to 2011 [40]. In the UK, hospital 319	
episode statistics show that there were over 108,000 admissions to NHS hospitals from 2005 to 320	
2014, where hypothermia was the primary or secondary cause [4]. This database also shows that 321	
the very young (0-4 years; 43,868 admissions) and the elderly (≥ 65 years; 48,477 admissions) 322	
make up 85% of the total admissions. This is concerning for two reasons. Firstly, acetaminophen 323	
is the most frequently administered analgesic among frail and pre-frail elderly individuals [41], 324	
with no age-related delay in drug absorption [42]. Secondly, acetaminophen is commonly used 325	
for neonatal pain management [43]. In the perioperative setting, Tc monitoring after 326	
acetaminophen administration in these vulnerable groups is recommended. A 2011 study showed 327	
that intravenous acetaminophen (~20 mg/kg) did not cause hypothermia in 93 neonates [44]. 328	
However, the ambient temperature was not reported (presumably 23-25°C), and only the skin 329	
temperature was measured. This is problematic since our work showed a clear reduction in Tc 330	
without a change in skin temperature between acetaminophen and placebo [13]. Moreover, 331	
neonates are exposed to cold stress when wet with amniotic fluid, during transportation, or 332	
during surgery. Based on our data, we propose that acetaminophen may increase the risk of 333	
neonatal hypothermia only when coupled with one of these cold stressors, and not in a thermo-334	
neutral environment.  335	
1.4.1 Limitations  336	
This study has limitations that should be considered in future work. Firstly, we did not measure 337	
metabolic heat production or cutaneous blood flow, key parameters that control Tc during cold 338	
stress. Although a reduction in Tc from resting value is the primary variable of interest from a 339	
medical standpoint, it is still unknown what aspect of the thermoregulatory system 340	
acetaminophen targets to exert this effect. Measuring metabolic heat production and changes in 341	
cutaneous blood flow in future studies of a similar design may help to elucidate the mechanism 342	
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that regulates acetaminophen’s hypothermic action. Secondly, no pharmacokinetic parameters 343	
are reported in this experiment. Disparity in the plasma concentration of acetaminophen 344	
throughout each trial may have explained the between subject variability in the hypothermic 345	
response elicited by acetaminophen i.e. a low plasma concentration may result in a reduced 346	
hypothermic response. We administered a dose relative to lean body mass to reduce the 347	
variability in acetaminophen absorption, and our previous experiment showed that a 20 mg/kg 348	
lean body mass dose was appropriate for therapeutic plasma concentrations to be reached within 349	
the 120-minute exposure period [13].  350	
1.4.2 Conclusions 351	
In conclusion, this preliminary trial demonstrated that acute acetaminophen ingestion (20 mg/kg 352	
lean body mass) reduced Tc maintenance during acute cold exposure in healthy young adults. We 353	
are the first to show that the hypothermic action of acetaminophen is strongly influenced by the 354	
ambient temperature in which it is administered. Future research should determine if this effect is 355	
amplified in new-borns and in elderly individuals, placing them at risk of accidental 356	
hypothermia. It should also be determined if hypothermic effects are limited to acetaminophen, 357	
or are present in COX inhibitors such as Ibuprofen and Aspirin (non-selective COX inhibitors), 358	
or COXIBs (COX-2 selective inhibitors). If all COX inhibitors induce hypothermia during cold 359	
exposure, the prescription of these medications to individuals vulnerable to hypothermia should 360	
be carefully considered during cold spells and in the perioperative period.  361	
  362	
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Figure Captions: 379	
Fig 1. A flowchart of the study design. APAP = Acetaminophen. Visits 2-5 completed in a 380	
randomised order for each participant. Visits separated by 1-week and drug administration 381	
double blinded. 382	
Fig 2. Mean and SD of the Tc (A, C) and Tsk (B, D) response during the 120-minute exposure to 383	
25°C (left panel i.e. A, B) and 10°C (right panel i.e. C, D). The triangles and squares represent 384	
the placebo and acetaminophen trials, respectively. ∗	Main effect for condition. # Main effect for 385	
time. † Interaction effect. Significance set at p < 0.05.  386	
Fig 3. Change in Tc during cold exposure in each participant following administration of a 387	
placebo (A) or acetaminophen (B). 388	
  389	
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Table 1. Descriptive data for each of the five response variables in the thermo-neutral condition (25°C). Descriptive data are the mean 
values (± standard deviation) during the 120-minute exposure period. The range is provided in parentheses. 
 Time-point (minutes) 
  Pre 30 60 90 120 
Tc (°C) 
Placebo 37.00 ± 0.13 (36.80 - 37.15) 
36.93 ± 0.15 
(36.72 - 37.13) 
36.95 ± 0.15 
(36.73 - 37.15) 
36.94 ± 0.14 
(36.75 - 37.15) 
36.94 ± 0.16 
(36.74 - 37.21) 
Acetaminophen 37.04 ± 0.20 (36.78 - 37.25) 
36.95 ± 0.22 
(36.78 - 37.14) 
36.93 ± 0.21 
(36.77 - 37.05) 
36.91 ± 0.23 
(36.68 - 37.10) 
36.89 ± 0.19 
(36.62 - 37.10) 
       
Tsk (°C) 
Placebo 30.6 ± 0.9 (28.7 - 31.8) 
30.9 ± 0.7 
(29.9 - 31.9) 
30.8 ± 0.7 
(29.8 - 31.7) 
30.7 ± 0.7 
(29.5 - 31.8) 
30.7 ± 0.7 
(29.3 - 31.7) 
Acetaminophen 30.3 ± 0.6 (29.0 - 31.1) 
30.8 ± 0.5 
(29.9 - 31.4) 
30.7 ± 0.4 
(29.9 - 31.2) 
30.7 ± 0.5 
(29.9 - 31.5) 
30.6 ± 0.6 
(29.6 - 31.6) 
       
HR (b/min) 
Placebo 65 ± 8 (53 - 79) 
59 ± 8 
(50 - 76) 
58 ± 10 
(46 - 79) 
58 ± 9 
(48 - 74) 
60 ± 10 
(49 - 86) 
Acetaminophen 68 ± 8 (53 - 81) 
62 ± 10 
(49 - 80) 
65 ± 10 
(50 - 84) 
59 ± 7 
(49 – 68) 
59 ± 10 
(42 - 71) 
       
TS (0 to 8 
scale) 
Placebo 4.0 ± 0.1 (4.0 - 4.5) 
4.1 ± 0.3 
(4.0 - 5.0) 
4.2 ± 0.4 
(4.0 - 5.0) 
4.3 ± 0.4 
(4.0 - 5.0) 
4.4 ± 0.6 
(4.0 - 5.5) 
Acetaminophen 4.0 ± 0.2 (3.5 - 4.5) 
4.2 ± 0.3 
(4.0 - 5.0) 
4.3 ± 0.4 
(4.0 - 5.0) 
4.4 ± 0.4 
(4.0 - 5.0) 
4.6 ± 0.5 
(4.0 - 5.0) 
       
MAP 
(mmHg) 
Placebo 91 ± 7 (83 - 103) 
91 ± 9 
(73 - 101) 
91 ± 10 
(81 - 113) 
92 ± 4 
(88 -  99) 
90 ± 6 
(82 - 99) 
Acetaminophen 88 ± 6 (80 - 97) 
91 ± 6 
(82 - 100) 
88 ± 9 
(78 - 111) 
88 ± 5 
(83 - 97) 
91 ± 6 
(85 - 104) 
Core temperature (Tc), Skin temperature (Tsk), Heart rate (HR), Thermal sensation (TS), Mean arterial pressure (MAP) 
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Table 2. Descriptive data for each of the five response variables in the cold condition (10°C). Descriptive data are the mean values (± 
standard deviation) during the 120-minute exposure period. The range is provided in parentheses. 
 Time-point (minutes) 
  Pre 30 60 90 120 
Tc (°C) 
Placebo 36.98 ± 0.20 (36.70 - 37.13) 
37.09 ± 0.19 
(36.79 - 37.38) 
37.03 ± 0.22 
(36.72 - 37.34) 
36.97 ± 0.23 
(36.71 - 37.29) 
36.96 ± 0.25 
(36.64 - 37.19) 
Acetaminophen 36.97 ± 0.21 (36.61 - 37.36) 
37.05 ± 0.26 
(36.59 - 37.49) 
36.94 ± 0.31 
(36.52 - 37.45) 
36.76 ± 0.30* 
(36.33 - 37.29) 
36.58 ± 0.23* 
(36.11 - 36.87) 
       
Tsk (°C) 
Placebo 30.5 ± 0.5 (29.6 - 31.3) 
25.8 ± 1.0 
(24.7 - 27.6) 
24.9 ± 1.0 
(23.8 - 26.9) 
24.4 ± 1.0 
(23.2 - 26.5) 
24.2 ± 1.0 
(22.8 - 26.6) 
Acetaminophen 30.7 ± 0.7 (29.6 - 31.8) 
26.1 ± 1.0 
(24.7 - 28.2) 
25.1 ± 1.0 
(23.7 - 26.6) 
24.5 ± 1.2 
(23.0 - 26.3) 
24.3 ± 1.3 
(22.4 - 26.5) 
       
HR 
(b/min) 
Placebo 68 ± 7 (54 - 79) 
62 ± 9 
(48 - 74) 
61 ± 4 
(55 - 67) 
57 ± 8 
(48 - 68) 
60 ± 9 
(51 - 75) 
Acetaminophen 66 ± 11 (50 - 79) 
59 ± 9 
(41 - 70) 
58 ± 10 
(39 - 73) 
54 ± 7 
(42 - 64) 
57 ± 9 
(41 - 70) 
       
TS (0 to 8 
scale) 
Placebo 4.1 ± 0.2 (4.0 - 4.5) 
2.8 ± 0.4 
(2.0 - 3.0) 
2.3 ± 0.5 
(1.5 - 3.0) 
1.9 ± 0.2 
(1.5 - 2.0) 
1.8 ± 0.4 
(1.0 - 2.0) 
Acetaminophen 3.9 ± 0.2 (3.5 - 4.0) 
2.3 ± 0.4 
(2.0 - 3.0) 
2.2 ± 0.4 
(1.5 - 3.0) 
1.8 ± 0.6 
(1.0 - 3.0) 
1.7 ± 0.5 
(1.0 - 2.5) 
       
MAP 
(mmHg) 
Placebo 92 ± 10 (78 - 104) 
97 ± 9 
(86 - 112) 
99 ± 8 
(90 - 110) 
97 ± 7 
(88 - 111) 
105 ± 8 
(92 - 117) 
Acetaminophen 93 ± 6 (78 - 102) 
94 ± 9 
(74 - 102) 
103 ± 7 
(91 - 111) 
96 ± 6 
(88 - 104) 
99 ± 6 
(77 - 104) 
Core temperature (Tc), Skin temperature (Tsk), Heart rate (HR), Thermal sensation (TS), Mean arterial pressure (MAP). * denotes 
significant difference between the APAP and placebo condition (p < 0.05). 
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Table 3. Beta coefficients (B), 95 % confidence intervals (CI), alpha values (p), and the Phi 
coefficient are reported for the fixed components (drug & time) during exposure to cold stress 
(10ºC). The standard deviation of the intercept and residual are reported for the random effect 
(subject ID).  
    Core Temperature (ºC) 
    B CI p 
Fixed Parts  
Intercept   36.95 36.71 to 37.13 <.001 
Drug×Time Interaction     
DRUG:TIME10   0.03 -0.11 to 0.17 .694 
DRUG:TIME20   -0.03 -0.17 to 0.11 .672 
DRUG:TIME30   -0.06 -0.20 to 0.09 .442 
DRUG:TIME40   -0.10 -0.24 to 0.04 .179 
DRUG:TIME50   -0.12 -0.26 to 0.02 .109 
DRUG:TIME60   -0.13 -0.28 to 0.01 .076 
DRUG:TIME70   -0.18 -0.32 to -0.03 .021 
DRUG:TIME80   -0.21 -0.36 to -0.07 .006 
DRUG:TIME90   -0.24 -0.38 to -0.10 .002 
DRUG:TIME100   -0.29 -0.43 to -0.15 <.001 
DRUG:TIME110   -0.31 -0.45 to -0.17 <.001 
DRUG:TIME120   -0.36 -0.50 to -0.22 <.001 
Phi Coefficient  
0.938 
Random Parts (Subject ID) 
  Standard Deviation 
Intercept   0.13 
Residual   0.16 
 
